10991ImmunoCult Human CD3CD28 T Cell Activator
State & local contract award Virginia Awarded
- Contract number
- A236_P0343203
- Awardee
- StemCell Technologies Inc
- Contracting organization
- Virginia Commonwealth University
- Cumulative value
- $998.00
About this award
Virginia Commonwealth University awarded a contract to StemCell Technologies Inc. on June 29, 2026, for the supply of immunological research materials. The contract, designated A236_P0343203, is valued at $998 and will be performed in Virginia. The prime contractor will deliver one unit of ImmunoCult Human CD3CD28 T Cell Activator to VCU Procurement, a specialized reagent used in T cell research and activation protocols.
This procurement appears to support Virginia Commonwealth University's research operations through the acquisition of a single unit of specialized laboratory reagent. The contract represents a minimal-value purchase order characteristic of routine supplies for academic research institutions. No specific performance period beyond the award date of June 29, 2026, is identified in the contract documentation provided.
Line items
| Item | Total |
|---|---|
| 10991ImmunoCult Human CD3CD28 T Cell Activator | $998.00 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A236_P0343203?
Contract A236_P0343203 was awarded to StemCell Technologies Inc by Virginia Commonwealth University on June 29, 2026.
How much is contract A236_P0343203 worth?
Its cumulative value is $998.00.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award